Metabolomic profiling of liver tissues after acute administration of vardenafil in rats.

Erectile dysfunction Kreb’s cycle Metabolomics Q-TOF MS Vardenafil

Journal

Veterinary research forum : an international quarterly journal
ISSN: 2008-8140
Titre abrégé: Vet Res Forum
Pays: Iran
ID NLM: 101625812

Informations de publication

Date de publication:
2020
Historique:
received: 18 10 2018
accepted: 19 01 2019
entrez: 2 11 2020
pubmed: 3 11 2020
medline: 3 11 2020
Statut: ppublish

Résumé

Erectile dysfunction (ED) diseases have almost affected 100 million men all over the world. Orally administered phosphodiesterase 5 (PDE 5) inhibitors are the most used pharmaceutical formulations for the treatment of ED. In this study, it is aimed to investigate the metabolomics feature of orally administered vardenafil in rats. To carry out the experimental procedure eight male Wistar albino rats were used. Their livers were gently removed and metabolomics profiles of each sample were determined by UPLC Q-TOF MS. Identification of metabolites was achieved by the METLIN database. Cluster analysis was also performed via Principle Component Analysis. Several metabolites were identified and results were evaluated by XCMS software. UPLC Q-TOF MS could be successfully applied to profile biomarkers and help us understand the molecular mechanisms of vardenafil usage. It was concluded that the level of some metabolites, responsible for the collagen synthesis and Kreb's cycle, has been statistically significant after the vardenafil administration.

Identifiants

pubmed: 33133457
doi: 10.30466/vrf.2019.95959.2302
pmc: PMC7597791
doi:

Types de publication

Journal Article

Langues

eng

Pagination

213-217

Informations de copyright

© 2020 Urmia University. All rights reserved.

Références

J Pharm Anal. 2014 Dec;4(6):360-367
pubmed: 29403901
Biomed Pharmacother. 2002 Nov;56(9):446-57
pubmed: 12481981
J Androl. 2002 Nov-Dec;23(6):763-71
pubmed: 12399521
Urology. 2004 Dec;64(6):1187-95
pubmed: 15596195
Br J Pharmacol. 2009 Mar;156(6):909-19
pubmed: 19298393
Int J Impot Res. 1997 Sep;9(3):141-8
pubmed: 9315491
Mol Biosyst. 2013 Nov;9(11):2618-26
pubmed: 23959290
Mol Cell Biochem. 1983;51(1):61-6
pubmed: 6855750
Front Bioeng Biotechnol. 2015 Mar 05;3:23
pubmed: 25798438
Anal Chem. 2011 Aug 1;83(15):5864-72
pubmed: 21526840
Nat Rev Urol. 2016 Mar;13(3):126
pubmed: 26856882
Int J Impot Res. 2000 Feb;12(1):41-5
pubmed: 10982311
Ann Pharmacother. 2005 Jul-Aug;39(7-8):1286-95
pubmed: 15941818
Clin J Am Soc Nephrol. 2006 May;1(3):441-7
pubmed: 17699243

Auteurs

Onur Şenol (O)

Department of Analytical Chemistry, Faculty of Pharmacy, Atatürk University, Erzurum, Turkey.

Şaziye Sezin Palabiyik (ŞS)

Department of Toxicology, Faculty of Pharmacy, Atatürk University, Erzurum, Turkey.

Beyzagül Polat (B)

Department of Pharmacology, Faculty of Pharmacy, Atatürk University, Erzurum, Turkey.

Yücel Kadioğlu (Y)

Department of Analytical Chemistry, Faculty of Pharmacy, Atatürk University, Erzurum, Turkey.

Mehmet Emrah Yaman (ME)

Department of Analytical Chemistry, Faculty of Pharmacy, Atatürk University, Erzurum, Turkey.

Classifications MeSH